Theralase Technologies Inc. (CVE:TLT – Get Free Report)’s share price dropped 1.6% on Friday . The stock traded as low as C$0.29 and last traded at C$0.30. Approximately 41,605 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 138,317 shares. The stock had previously closed at C$0.31.
Theralase Technologies Stock Performance
The company has a fifty day moving average of C$0.27 and a two-hundred day moving average of C$0.22. The stock has a market capitalization of C$73.66 million, a P/E ratio of -15.00 and a beta of 1.36. The company has a debt-to-equity ratio of 20.58, a current ratio of 1.21 and a quick ratio of 3.40.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Further Reading
- Five stocks we like better than Theralase Technologies
- How to Read Stock Charts for Beginners
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- 3 Warren Buffett Stocks to Buy Now
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
